EW (Edwards Lifesciences) Other Current Liabilities: $281 Mil (As of Mar. 2026)


EW Edwards Lifesciences Corp EW
97 GF Score
Price $94.37
GF Value $93.37
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Edwards Lifesciences Other Current Liabilities?

Edwards Lifesciences EW +2.59% 97 Other Current Liabilities is $281 Mil as of Mar. 2026. GuruFocus rates EW with a GF Score™ of 97/100 and a GF Value™ of $93.37 (Fairly Valued). The stock has 5 warning signs investors should review.

Edwards Lifesciences's other current liabilities for the quarter that ended in Mar. 2026 was $281 Mil.

Edwards Lifesciences's quarterly other current liabilities increased from Sep. 2025 ($539 Mil) to Dec. 2025 ($543 Mil) but then declined from Dec. 2025 ($543 Mil) to Mar. 2026 ($281 Mil).

Edwards Lifesciences's annual other current liabilities declined from Dec. 2023 ($530 Mil) to Dec. 2024 ($443 Mil) but then increased from Dec. 2024 ($443 Mil) to Dec. 2025 ($543 Mil).

Edwards Lifesciences Other Current Liabilities Related Terms

Edwards Lifesciences Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Edwards Lifesciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences Other Current Liabilities Chart

Edwards Lifesciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 342.70 305.00 530.20 442.70 542.80

Edwards Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 399.10 486.50 539.00 542.80 280.50
EW
97GF Score
Edwards Lifesciences Corp EW
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edwards Lifesciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $281 Mil mean?
Edwards Lifesciences (EW) has a Other Current Liabilities of $281 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Edwards Lifesciences.
Is Edwards Lifesciences' Other Current Liabilities too high?
Edwards Lifesciences' current Other Current Liabilities is $281 Mil. Overall, Edwards Lifesciences has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' Other Current Liabilities compare to BSX and GEHC?
Edwards Lifesciences' Other Current Liabilities of $281 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Edwards Lifesciences. Edwards Lifesciences's current Other Current Liabilities is $281 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Edwards Lifesciences (EW) is currently considered Fairly Valued. The stock's GF Value™ is $93.37, compared to a current price of $94.37 — trading 1.1% above its estimated fair value. The current Other Current Liabilities is $281 Mil. Edwards Lifesciences' overall GF Score™ is 97/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Edwards Lifesciences (EW), the current Other Current Liabilities is $281 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edwards Lifesciences (EW) Overvalued in 2026?

Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be overvalued. The current stock price of $94.37 is trading 1.1% above its estimated GF Value™ of $93.37. GuruFocus considers Edwards Lifesciences to be Fairly Valued.

Key valuation signals for EW:

  • Other Current Liabilities: $281 Mil
  • GF Value™: $93.37 vs. price of $94.37 (1.1% above fair value)
  • GF Score™: 97/100 with 5 warning signs

No single metric tells the full story. See the EW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Edwards Lifesciences Business Description

Address One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
97GF Score

Get the complete analysis for EW

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$94.37
Price
$93.37
GF Value